Title: Transcatheter arterial embolization for advanced hepatocellular carcinoma: The controversy continues
Abstract: HepatologyVolume 27, Issue 6 p. 1743-1744 EditorialFree Access Transcatheter arterial embolization for advanced hepatocellular carcinoma: The controversy continues Shuichi Okada M.D., Ph.D., M.D., Ph.D, Corresponding Author Shuichi Okada M.D., Ph.D., M.D., Ph.D From the Department of Internal Medicine, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, JapanDepartment of Internal Medicine, National Cancer Center, Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. Fax: 81-3-3542-3815===Search for more papers by this author Shuichi Okada M.D., Ph.D., M.D., Ph.D, Corresponding Author Shuichi Okada M.D., Ph.D., M.D., Ph.D From the Department of Internal Medicine, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, JapanDepartment of Internal Medicine, National Cancer Center, Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. Fax: 81-3-3542-3815===Search for more papers by this author First published: 30 December 2003 https://doi.org/10.1002/hep.510270639Citations: 33AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. REFERENCES 1 Okada S, Shimada K, Yamamoto J, Takayama T, Kosuge T, Yamasaki S, Sakamoto M, et al. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 1994; 106: 1618– 1624.MEDLINE 2 Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954; 30: 969– 985. 3 Nakamura H, Tanaka T, Hori S, Yoshioka H, Kuroda C, Okamura J, Sakurai M. Transcatheter embolization of hepatocellular carcinoma: assessment of efficacy in cases of resection following embolization. Radiology 1983; 147: 401– 405.MEDLINE 4 Barth KH, Strandberg JD, White RI. Long term follow-up of transcatheter embolization with autologous clot, oxycel and gelfoam in domestic swine. Invest Radiol 1977; 12: 273– 280.MEDLINE 5 Takayasu K, Shima Y, Muramatsu Y, Moriyama N, Yamada T, Makuuchi M, Hasegawa H, et al. Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 1987; 162: 345– 351.MEDLINE 6 Vetter D, Wenger JJ, Bergier JM, Doffoel M, Bockel R. Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: results of a Western comparative study in 60 patients. Hepatology 1991; 13: 427– 433.MEDLINE 7 Lin DY, Liaw YF, Lee TY, Lai CM. Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma––a randomized controlled trial. Gastroenterology 1988; 94: 453– 456.MEDLINE 8 Pelletier G, Roche A, Ink O, Anciaux ML, Derhy S, Rougier P, Lenoir C, et al. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 1990; 11: 181– 184.MEDLINE 9 Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995; 332: 1256– 1261.MEDLINE 10 Rougier P, Pelletier G, Ducreux M, Gay F, Luboinski M, Hagège H, Dao T, et al. Unresectable hepatocellular carcinoma: lack of efficacy of lipiodol chemoembolization. Final results of a multicenter randomized trial [Abstract]. Proc Am Soc Clin Oncol 1997; 16: 279a. 11 Bruix J, Llovet JM, Castells A, Montaná X, Brú C, Ayuso MDC, Vilana R, et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma. Results of a randomized controlled trial in a single institute. Hepatology 1998; 28: 1578– 1583.MEDLINE 12 Okada S, Okazaki N, Nose H, Yoshimori M, Aoki K. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Hepatology 1992; 16: 112– 117.MEDLINE Citing Literature Volume27, Issue6June 1998Pages 1743-1744 ReferencesRelatedInformation